Total daily physical activity and the risk of AD and cognitive decline in older adults
暂无分享,去创建一个
[1] A. Lutterotti,et al. Persistency of neutralizing antibodies depends on titer and interferon-beta preparation , 2012, Multiple sclerosis.
[2] F. Deisenhammer,et al. Alemtuzumab more effective than interferon β-1a at 5-year follow-up of CAMMS223 clinical trial , 2012, Neurology.
[3] W. Markesbery,et al. Healthy ageing in the Nun Study: definition and neuropathologic correlates. , 2007, Age and ageing.
[4] D A Bennett,et al. Total daily physical activity and the risk of AD and cognitive decline in older adults , 2012, Neurology.
[5] Bernhard Hemmer,et al. Recommendations for clinical use of data on neutralising antibodies to interferon-beta therapy in multiple sclerosis , 2010, The Lancet Neurology.
[6] G. Rice,et al. Interferon β-1a in MS , 2005, Neurology.